Liquid Biopsies

The Protocol of Circulating Tumor Cell Detection.- Cell-free RNA sequencing from biofluid samples.- Detection of Circulating Tumor DNA in plasma using Targeted Sequencing.- Exosomal RNA sequencing from body fluid samples.- Detection of micro-organisms in body fluid samples.- The Interactome of Protein, DNA and RNA.- Liquid biopsy in bladder cancer.- CSF Biopsy in Glioma: ABrief Review.- Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.- The implication of liquid biopsy in the non-small cell lung cancer: potential and expectation.- Cell-free DNA, MicroRNAs, Proteins and Peptides as liquid biopsy biomarkers in prostate cancer and bladder cancer.-Identification of plasma metabolites associated with lung cancer survival.- The detection of exosomal PD-L1 in peripheral blood.- Liquid Biopsy in Hepatocellular Carcinoma.- Role of circulating tumor DNA in colorectal cancer.- The value of cell-free circulating DNA profiling in patients with skin diseases.- The value of cell-free circulating DNA profiling in patients with skin diseases.- Circulating non-coding RNAs and exosomes: liquid biopsies for monitoring preeclampsia.- Liquid Biopsy in Coronary Heart Disease.- The diagnostic and prognostic value of synovial fluid analysis in joint diseases.- Liquid biopsy, a potential new detection method in heart allograft rejection.- Potential value and application of liquid biopsy in tumor, neurodegeneration and muscle degenerative diseases.- Liquid biopsy in adverse neurodevelopment of children: problems and prospects.- Advances of liquid biopsy for diagnosis of atrial fibrillation and its recurrence after ablation in clinical application.